机构

• 上海药物研究所 [102]

采集方式

• OAI收割 [102]

内容类型

• 期刊论文 [102]

发表日期

• 2024 [4]
• 2023 [14]
• 2022 [11]
• 2021 [9]
• 2020 [14]
• 2019 [6]
• 更多

学科主题

• Biochemist... [2]
• Pharmacolo... [2]
• Biophysics [1]
• Cell Biolo... [1]
• Chemistry [1]

筛选

浏览/检索结果: 共102条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma 期刊论文  OAI收割 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 卷号: 754, 页码: 11 作者:  Lai, Yue;  Guo, Shushan;  Tang, Qiongwei;  Chang, Gaomei;  Zhang, Hui   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/07 Dihydrocelastrol  Angiogenesis  Apoptosis  Jun B  p65   Ribosomal protein S3 mediates drug resistance of proteasome inhibitor: potential therapeutic application in multiple myeloma 期刊论文  OAI收割 HAEMATOLOGICA, 2024, 卷号: 109, 期号: 4, 页码: 1206-1219 作者:  Chen, Gege;  Gao, Xuejie;  Jia, Xinyan;  Wang, Yingcong;  Xu, Li   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/07 A novel pterostilbene compound DCZ0825 induces macrophage M1 differentiation and Th1 polarization to exert anti-myeloma and immunomodulatory 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 卷号: 127, 页码: 14 作者:  Zhang, Hui;  Hu, Ke;  Lu, Yumeng;  Xu, Zhijian;  Chen, Gege   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/03/25 Multiple myeloma  M1 macrophages  Th1 cells  Immunomodulatory   Design and synthesis of cantharidin derivative DCZ5418 as a TRIP13 inhibitor with anti-multiple myeloma activity in vitro and in vivo 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 卷号: 98, 页码: 7 作者:  Dong, Sanfeng;  Hu, Ke;  Shi, Yulong;  Wang, Guanli;  Yu, Dandan   |  收藏  |  浏览/下载：11/0  |  提交时间：2024/02/19 Multiple myeloma  TRIP13 inhibitor  Cantharidin  DCZ5418  DCZ0415   Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 卷号: 125, 页码: 15 作者:  Feng, Qilin;  Hu, Ke;  Hu, Huifang;  Lu, Yumeng;  Zhang, Hui   |  收藏  |  浏览/下载：28/0  |  提交时间：2024/01/16 DLBCL  ROS  DNA damage  JNK  Mitochondrial dysfunction   Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation 期刊论文  OAI收割 ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 卷号: 55, 期号: 12, 页码: 1884-1891 作者:  Jin, Shuhan;  Li, Bo;  Zhang, Bibo;  Gao, Xuejie;  Jia, Xinyan   |  收藏  |  浏览/下载：12/0  |  提交时间：2024/02/27 dihydrocelastrol  multiple myeloma  JAK2/STAT3  PSMB5  bortezomib resistance   The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway 期刊论文  OAI收割 JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 卷号: 21, 期号: 1, 页码: 17 作者:  Wang, Yingcong;  Dong, Sanfeng;  Hu, Ke;  Xu, Li;  Feng, Qilin   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/01/26 Norcantharidin  Derivative  DCZ5417  TRIP13  Anti-myeloma  MAPK   Clinically Translatable Solid-State Dye for NIR-II Imaging of Medical Devices 期刊论文  OAI收割 ADVANCED SCIENCE, 2023, 页码: 13 作者:  Li, Deling;  Shi, Hui;  Qi, Qingrong;  Chang, Baisong;  Jiang, Yuanwen   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/19 aggregates  in vivo imaging  medical devices  NIR-II fluorescence   TI17, a novel compound, exerts anti-MM activity by impairing Trip13 function of DSBs repair and enhancing DNA damage 期刊论文  OAI收割 CANCER MEDICINE, 2023, 页码: 14 作者:  Chang, Shuaikang   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/12/11 DNA damage  DSBs repair  myeloma  TI17  Trip13   Otilonium Bromide acts as a selective USP28 inhibitor and exhibits cytotoxic activity against multiple human cancer cell lines 期刊论文  OAI收割 BIOCHEMICAL PHARMACOLOGY, 2023, 卷号: 215, 页码: 14 作者:  Xu, Zhuo;  Wang, Hui;  Meng, Qian;  Ding, Yiluan;  Zhu, Mengying   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Otilonium Bromide  Deubiquitinase  USP28  Selective inhibitor